“I’m guessing part of the thing is in relation to funding, but it’s also important to recognise – sometimes you have to actually look at something and say ‘this is something that is going to help save money for both the health system, and also deliver the best possible care for cancer patients’ – surely that’s a win-win situation?
Trending
- Targeting valine metabolism and ferroptosis to overcome chemoresistance in PDAC
- Advancing Childhood Cancer Research: Q&A with Dr. Brigitte Widemann
- Iberdomide in Lenalidomide-Refractory Multiple Myeloma
- FDA Approves TLX101-Px for PET Imaging in Patients With Glioma
- Most Appendix Cancer Patients Can Skip Chemo, Study Says
- Emerging CELMoDs in Multiple Myeloma
- Unlocking the clock: a systematic review and meta-analysis on optimizing immune checkpoint inhibitor timing for advanced solid tumors
- Lancashire cancer clinicians take on 140-mile charity bike ride

